Home The Word Brain	My Amedeo FAQ Privacy About
	Amedeo Chinese For Medical Students & Physicians A complete 20-lesson, 300-page Chinese course with a companion app in 21 languages — free forever. Download the free PDF: Amedeo Chinese PDF

Rheumatoid Arthritis

Free Subscription 14.09.2026 8 Ann Rheum Dis 8 Clin Rheumatol 1 Eur J Immunol 1 Intern Med 2 PLoS One 1 Scand J Rheumatol 6 Z Rheumatol

Retrieve available abstracts of this week’s articles: HTML format

Single Articles

Ann Rheum Dis

1. TERABE K, Asai S, Yoshioka Y, Kato T, et al
   Sequential disease activity assessment for predicting future treatment trajectories in patients with rheumatoid arthritis treated with JAK inhibitors: a group-based trajectory and landmark analysis.
   Ann Rheum Dis. 2026 Sep 10:S0003-4967(26)00495-4. doi: 10.1016/j.ard.2026.
   PubMed         Abstract available
   
   
2. SCHULEIN M, Afonso M, Sijbranda M, Pulgarin DV, et al
   A new humanised TCR transgenic mouse model to study T cells reactive to citrullinated tenascin C, a relevant autoantigen in rheumatoid arthritis.
   Ann Rheum Dis. 2026 Sep 10:S0003-4967(26)00492-9. doi: 10.1016/j.ard.2026.
   PubMed         Abstract available
   
   
3. AAMAR S
   Correspondence on 'EULAR recommendations for the management of rheumatoid arthritis with synthetic and biologic disease-modifying antirheumatic drugs: 2025 update' by Smolen et al and 'Spacing of a TNF inhibitor or dose reduction of methotrexate vs co
   Ann Rheum Dis. 2026;85:e98-e99.
   PubMed        
   
   
4. IMAI Y, Kono M, Ishii T, Kojima T, et al
   Response to correspondence on 'Spacing of a TNF inhibitor or dose reduction of methotrexate vs continued treatment in patients with rheumatoid arthritis in remission or low disease activity (SORAIRO trial)'.
   Ann Rheum Dis. 2026;85:e102-e103.
   PubMed        
   
   
5. SMOLEN JS, Edwards CJ, Konzett V, Laskou F, et al
   Response to correspondence by Dr Aamar on 'EULAR recommendations for the management of rheumatoid arthritis with synthetic and biologic disease-modifying antirheumatic drugs: 2025 update'.
   Ann Rheum Dis. 2026;85:e100-e101.
   PubMed        
   
   
6. ENGELKE F, Heidecke H, Schulze-Forster K, Bahre H, et al
   Functional insights into autoantibodies targeting muscarinic acetylcholine receptors in Sjogren's disease.
   Ann Rheum Dis. 2026;85:1774-1783.
   PubMed         Abstract available
   
   
7. ZONG Y, Yang Y, Zhao J, Wen S, et al
   Mitochondrial-impaired ductal epithelium fuels TLS formation in Sjogren's disease.
   Ann Rheum Dis. 2026;85:1784-1799.
   PubMed         Abstract available
   
   
8. WINTHROP KL, Kerschbaumer A, Isaacs JD, Mease P, et al
   Chasing the target: reports from the Advances in Targeted Therapies meeting, 2025.
   Ann Rheum Dis. 2026;85:1683-1693.
   PubMed         Abstract available
   
   

   
   Clin Rheumatol

9. LIN Y, Qu Y, Qiu X, Huan Q, et al
   Global population-level concurrence and directional associations between rheumatoid arthritis and depressive disorders: an SDI-stratified time-series analysis using GBD 2021.
   Clin Rheumatol. 2026 Sep 5. doi: 10.1007/s10067-026-08358.
   PubMed         Abstract available
   
   
10. KAUR R, Satpathy S
    Comment on "AI-based CT quantification reveals small airway loss and vascular simplification in rheumatoid arthritis-associated lung disease".
    Clin Rheumatol. 2026 Sep 7. doi: 10.1007/s10067-026-08330.
    PubMed        
    
    
11. LI L, Li Z, Liu F, Li M, et al
    Clinical characteristics and pulmonary-cause mortality in rheumatoid arthritis-associated interstitial lung disease by lung-onset status.
    Clin Rheumatol. 2026 Sep 8. doi: 10.1007/s10067-026-08399.
    PubMed         Abstract available
    
    
12. KISHIMOTO Y, Nakazawa K, Fukumoto Y, Kaneda R, et al
    Lower extremity osteoarthritis in elderly patients with rheumatoid arthritis: prevalence, radiographic-clinical discordance, and functional impact - a cross-sectional study.
    Clin Rheumatol. 2026 Sep 8. doi: 10.1007/s10067-026-08412.
    PubMed         Abstract available
    
    
13. GUO W, Li B, Tian H, Guo S, et al
    Autologous hematopoietic stem cell transplantation in a patient with rheumatoid arthritis and multiple myeloma: a case-based narrative literature review.
    Clin Rheumatol. 2026 Sep 8. doi: 10.1007/s10067-026-08406.
    PubMed         Abstract available
    
    
14. YAN J, Li Y, Su Y, Ba X, et al
    Sex and age influence the association between insulin resistance and all-cause mortality in rheumatoid arthritis patients.
    Clin Rheumatol. 2026 Sep 8. doi: 10.1007/s10067-026-08376.
    PubMed         Abstract available
    
    
15. HARMAN H, Islek T, Dogan D, Balci MA, et al
    Paradoxical psoriasis in axial spondyloarthritis and rheumatoid arthritis treated with b/tsDMARDs: a retrospective cohort study.
    Clin Rheumatol. 2026 Sep 11. doi: 10.1007/s10067-026-08417.
    PubMed         Abstract available
    
    
16. MEINHARDSSON JM, Hauge EM, Klose-Jensen R, Vanden-Bossche A, et al
    Histological validation of barium-filled vascular channels detected by high-resolution peripheral quantitative computed tomography in rheumatoid arthritis: an exploratory cadaveric study.
    Clin Rheumatol. 2026 Sep 12. doi: 10.1007/s10067-026-08419.
    PubMed         Abstract available
    
    

    
    Eur J Immunol

17. XU L, Zhan M, Wei Z, Dong S, et al
    Altered Peripheral and Synovial CD8(+) T Cell Signatures Are Associated With Disease Activity in Female Early-Stage Rheumatoid Arthritis.
    Eur J Immunol. 2026;56:e70279.
    PubMed         Abstract available
    
    

    
    Intern Med

18. HAYASHI N, Yamada S, Ohno Y, Fujisawa Y, et al
    Limited Joint Mobility Syndrome Mimicking Rheumatoid Arthritis in a Patient with Type 2 Diabetes Mellitus: A Case Report.
    Intern Med. 2026 Sep 8. doi: 10.2169/internalmedicine.8077.
    PubMed         Abstract available
    
    

    
    PLoS One

19. AHMAD A, Khalil S, Law D, De Los Rios-Escalante PR, et al
    Integrative network analysis identifies candidate genes shared between ferroptosis and cuproptosis pathways in rheumatoid arthritis pathogenesis.
    PLoS One. 2026;21:e0358176.
    PubMed         Abstract available
    
    
20. SOBEJANA MM, Korpershoek RM, Steinz MM, van der Laken CJ, et al
    Effects of exercise on muscle strength and characteristics in rheumatic diseases and sarcopenia: Protocol for the Care for Muscle (C4M) Study.
    PLoS One. 2026;21:e0356181.
    PubMed         Abstract available
    
    

    
    Scand J Rheumatol

21. IKEN AR, van Bodegom-Vos L, Vliet Vlieland T, van Gaalen FA, et al
    Prevalence of severe functional limitations and physical therapy use in patients with rheumatoid arthritis or axial spondyloarthritis: a multicentre cross-sectional study in the Netherlands.
    Scand J Rheumatol. 2026 Sep 8:1-10. doi: 10.1080/03009742.2026.2711489.
    PubMed         Abstract available
    
    

    
    Z Rheumatol

22. ERNST D, Zehrfeld N
    [Current treatment, foreseeable newcomer and new treatment approaches for Sjogren's disease].
    Z Rheumatol. 2026;85:536-544.
    PubMed         Abstract available
    
    
23. FINZEL S
    [Diagnostics of Sjogren's disease].
    Z Rheumatol. 2026;85:520-526.
    PubMed         Abstract available
    
    
24. BRAUN J, Dorner T
    [Practical management of Sjogren's disease in the era of new treatment options : Current value of available outcome parameters].
    Z Rheumatol. 2026;85:527-535.
    PubMed         Abstract available
    
    
25. ERNST D, Dorner T, Aringer M, Finzel S, et al
    [Proposal of the rheumatology societies in the D-A-CH region for a uniform German nomenclature for Sjogren's disease].
    Z Rheumatol. 2026;85:558-560.
    PubMed         Abstract available
    
    
26. RITTER J, Dorner T
    [Pathophysiological aspects of primary Sjogren's disease : From epithelial activation to systemic autoimmunity].
    Z Rheumatol. 2026;85:511-519.
    PubMed         Abstract available
    
    
27. ARINGER M, Tausche AK
    [Epidemiology and manifestations of Sjogren's disease].
    Z Rheumatol. 2026;85:505-510.
    PubMed         Abstract available
    
    

Thank you for your interest in scientific medicine.

AMEDEO Rheumatoid Arthritis is free of charge. Privacy / Datenschutzerklärung | Imprint / Impressum